{
  "id": 17208794,
  "title": "Eating disorders are on the rise. GLP-1s could make things worse.",
  "url": "https://urgent.news/2026/10/30/eating-disorders-are-on-the-rise-glp-1s-could-make-things-worse",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-30T09:00:00.000Z",
  "source": {
    "name": "MIT Tech Review Biotech",
    "slug": "mit-tech-review-biotech",
    "url": "https://www.technologyreview.com/2026/10/30/1147838/eating-disorders-rise-glp-1s-weight-loss-drugs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}